MCTA — Charming Medical Cashflow Statement
0.000.00%
Last trade - 00:00- $497.21m
- $494.88m
- $6.22m
Annual cashflow statement for Charming Medical, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -0.336 | 0.822 | 1.2 |
| Depreciation | |||
| Deferred Taxes | |||
| Non-Cash Items | 0.061 | -0.037 | -0.011 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 2.58 | -0.943 | -1.16 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Other Assets | |||
| Change in Payable / Accrued Expenses | |||
| Change in Taxes Payable | |||
| Change in Other Liabilities | |||
| Cash from Operating Activities | 2.43 | 0.295 | 0.426 |
| Capital Expenditures | -0.606 | -0.211 | -0.288 |
| Purchase of Fixed Assets | |||
| Other Investing Cash Flow Items | — | — | -1.94 |
| Purchase of Investments | |||
| Cash from Investing Activities | -0.606 | -0.211 | -2.23 |
| Financing Cash Flow Items | -1.25 | 0.216 | 0.472 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | -1.43 | 0.1 | 0.521 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 0.403 | 0.174 | -1.29 |